Your browser doesn't support javascript.
loading
Efficacy of Immune Checkpoint Inhibitors in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC).
Jeanson, Arnaud; Tomasini, Pascale; Souquet-Bressand, Maxime; Brandone, Nicolas; Boucekine, Mohamed; Grangeon, Mathieu; Chaleat, Solène; Khobta, Natalyia; Milia, Julie; Mhanna, Laurent; Greillier, Laurent; Biemar, Julie; Nanni, Isabelle; Ouafik, L'houcine; Garcia, Stéphane; Mazières, Julien; Barlesi, Fabrice; Mascaux, Céline.
Affiliation
  • Jeanson A; Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Department of Multidisciplinary Oncology and Therapeutic Innovations. Marseille, France; Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm UMR1068, CNRS UMR7258, Marseille, France.
  • Tomasini P; Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Department of Multidisciplinary Oncology and Therapeutic Innovations. Marseille, France; Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm UMR1068, CNRS UMR7258, Marseille, France.
  • Souquet-Bressand M; Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Department of Multidisciplinary Oncology and Therapeutic Innovations. Marseille, France.
  • Brandone N; Department of Pathology, Assistance Publique-Hôpitaux de Marseille (AP-HM), Aix-Marseille Université, Marseille, France.
  • Boucekine M; EA 3279 - Public Health, Chronic Diseases and Quality of Life-Research Unit, Aix-Marseille University, Marseille, France.
  • Grangeon M; Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Department of Multidisciplinary Oncology and Therapeutic Innovations. Marseille, France.
  • Chaleat S; Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Department of Multidisciplinary Oncology and Therapeutic Innovations. Marseille, France.
  • Khobta N; Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Department of Multidisciplinary Oncology and Therapeutic Innovations. Marseille, France; Centre Hospitalier Departemental de Castellucio, Oncology Department, Ajaccio, France.
  • Milia J; Department of Pulmonology, Hôpital Larrey, Centre Hospitalier Universitaire, Paul Sabatier University, Toulouse, France.
  • Mhanna L; Department of Pulmonology, Hôpital Larrey, Centre Hospitalier Universitaire, Paul Sabatier University, Toulouse, France.
  • Greillier L; Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Department of Multidisciplinary Oncology and Therapeutic Innovations. Marseille, France; Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm UMR1068, CNRS UMR7258, Marseille, France.
  • Biemar J; Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Department of Multidisciplinary Oncology and Therapeutic Innovations. Marseille, France.
  • Nanni I; Aix-Marseille University, APHM, CHU Nord, Service de Transfert d'Oncologie Biologique, Marseille, France.
  • Ouafik L; Aix-Marseille University, APHM, CHU Nord, Service de Transfert d'Oncologie Biologique, Marseille, France; Aix-Marseille University, CNRS, INP, Neurophysiopathology Institute, Marseille, France.
  • Garcia S; Department of Pathology, Assistance Publique-Hôpitaux de Marseille (AP-HM), Aix-Marseille Université, Marseille, France.
  • Mazières J; Department of Pulmonology, Hôpital Larrey, Centre Hospitalier Universitaire, Paul Sabatier University, Toulouse, France.
  • Barlesi F; Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Department of Multidisciplinary Oncology and Therapeutic Innovations. Marseille, France; Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm UMR1068, CNRS UMR7258, Marseille, France. Electronic address: fabrice.barlesi@
  • Mascaux C; Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Department of Multidisciplinary Oncology and Therapeutic Innovations. Marseille, France; Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm UMR1068, CNRS UMR7258, Marseille, France.
J Thorac Oncol ; 14(6): 1095-1101, 2019 06.
Article in En | MEDLINE | ID: mdl-30738221
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proto-Oncogene Proteins p21(ras) / Carcinoma, Non-Small-Cell Lung / Antineoplastic Agents, Immunological / Lung Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Middle aged Language: En Journal: J Thorac Oncol Year: 2019 Document type: Article Affiliation country: Francia Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proto-Oncogene Proteins p21(ras) / Carcinoma, Non-Small-Cell Lung / Antineoplastic Agents, Immunological / Lung Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Middle aged Language: En Journal: J Thorac Oncol Year: 2019 Document type: Article Affiliation country: Francia Country of publication: Estados Unidos